Clinical Trials Directory

Trials / Sponsors / Urovant Sciences GmbH

Urovant Sciences GmbH

Industry · 11 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC
Neurogenic Detrusor Overactivity
Phase 2 / Phase 32022-10-12
CompletedComposur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)
Overactive Bladder
—2021-10-28
CompletedURO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence
Overactive Bladder With Urge Urinary Incontinence
Phase 22019-12-16
CompletedExtension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benig
Overactive Bladder
Phase 32019-09-19
CompletedStudy to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Sympt
Overactive Bladder
Phase 32019-03-26
CompletedStudy to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable
Irritable Bowel Syndrome
Phase 22018-12-31
CompletedAn Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactiv
Overactive Bladder
Phase 32018-06-14
CompletedA Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)
Overactive Bladder
Phase 32018-03-26
CompletedPhase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for ED
Erectile Dysfunction
Phase 22015-04-01
CompletedPhase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer
Overactive Bladder
Phase 12013-01-01
TerminatedSafety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity
Overactive Bladder
Phase 12007-04-01